- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Baker City Today
By the People, for the People
Chemed Corporation Shareholders Encouraged to Seek Potential Recovery
Johnson Fistel investigating potential claims on behalf of Chemed investors following missed earnings estimates
Published on Feb. 26, 2026
Got story updates? Submit your updates here. ›
Johnson Fistel, PLLP, a national shareholder-rights law firm, is investigating potential claims on behalf of investors of Chemed Corporation (NYSE: CHE) following the company's recent fourth quarter 2025 financial results that missed consensus estimates. The firm is looking into whether Chemed complied with federal securities laws and if investor losses may be recovered.
Why it matters
Chemed's missed earnings and subsequent stock decline have raised concerns among investors, prompting a legal investigation into the company's practices and potential recovery of losses. As a prominent shareholder-rights firm, Johnson Fistel's actions could have significant implications for Chemed investors and the broader financial landscape.
The details
On February 26, 2026, Chemed reported its fourth quarter 2025 financial results, including adjusted earnings per share of $6.42 on revenue of $639.3 million. These results missed consensus estimates by approximately $0.61 per share and $19.8 million in revenue. Following these disclosures, Chemed's shares declined on February 26, 2026. In light of these disclosures, Johnson Fistel is investigating whether Chemed complied with the federal securities laws and if investor losses may be recovered.
- Chemed reported its Q4 2025 financial results on February 26, 2026.
- Chemed's shares declined on February 26, 2026 following the earnings miss.
The players
Johnson Fistel, PLLP
A nationally recognized shareholder-rights law firm that is investigating potential claims on behalf of Chemed Corporation investors.
Chemed Corporation
A publicly traded company (NYSE: CHE) that recently reported fourth quarter 2025 financial results that missed consensus estimates.
What they’re saying
“If you purchased Chemed securities and suffered losses on your investment, join our investigation now.”
— Jim Baker, Attorney (Globe Newswire)
What’s next
The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.
The takeaway
This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.
